Supplemental Figures from Arginase Therapy Combines Effectively with Immune Checkpoint Blockade or Agonist Anti-OX40 Immunotherapy to Control Tumor Growth
Authors:
- Mark D. BadeauxMBMark D. Badeaux
- Annah S. RoligARAnnah S. Rolig
- Giulia AgnelloGAGiulia Agnello
- Danlee EnzlerDEDanlee Enzler
- Melissa J. KasiewiczMKMelissa J. Kasiewicz
- Leslie PriddyLPLeslie Priddy
- Jason F. WigginsJWJason F. Wiggins
- Alexander MuirAMAlexander Muir
- Mark R. SullivanMSMark R. Sullivan
- Jessica Van CleefJCJessica Van Cleef
- Christopher DaigeCDChristopher Daige
- Matthew G. Vander HeidenMHMatthew G. Vander Heiden
Open Access
- 4 April 2023
- other
- Published by American Association for Cancer Research (AACR)